Fundraising FoxIdun Pharmaceuticals
San Diego, US · Delaware corporation · 5 known investors
Find your way into Idun Pharmaceuticals
Sign up to see every warm intro you have to Idun Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Idun Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SJ
Steven J. Mento, Ph.D.Executive
DF
David F. HaleExecutive
Board
PK
Paul KlingensteinBoard director
LL
Louis LacasseBoard director
JS
James ScopaBoard director
SM
Shahzad MalikBoard director
MO
Marc O. PerretBoard director
HV
Harold Van Wart, Ph.D.Board director
WG
William Gerber, M.D.Board director
Investors · 5
Prospect Venture Partnerslisted by Prospect Venture PartnersMenlo Park · $3M – $5M
How we know: Prospect Venture Partners's portfolio page · funding news · Not right? Tell us
Venrocklisted by VenrockPalo Alto · $500K – $10M
How we know: funding news · Not right? Tell us
MPM BioImpactreportedBoston · $1M – $15M
How we know: a partner's Signal profile · funding news · Not right? Tell us
RBC Capitalreported
How we know: a partner's Signal profile · Not right? Tell us
Sutter Hill VenturesreportedPalo Alto · $100K – $5M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$3.1M disclosed across 2 rounds · 2014–2015
▶$1.1MraisedJul 2015 · 30 investors · PharmaceuticalsRule 506(b)
▶$1.1MraisedJul 2015 · 30 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Paul KlingensteinDirector
- Louis LacasseDirector
- William Gerber, M.D.Director
- Harold Van Wart, Ph.D.Director
- Marc O. PerretDirector
- Shahzad MalikDirector
- James ScopaDirector
- Steven J. Mento, Ph.D.Director
- David F. HaleExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- Minimum investment
- $1
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedFeb 2015 · 30 investors · PharmaceuticalsRule 506(b)
▶$2MraisedFeb 2015 · 30 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Steven J. Mento, Ph.D.Director
- Paul KlingensteinDirector
- Harold Van Wart, Ph.D.Director
- Louis LacasseDirector
- William Gerber, M.D.Director
- David F. HaleExecutive Officer, Director
- James ScopaDirector
- Shahzad MalikDirector
- Marc O. PerretDirector
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $1
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Idun Pharmaceuticals's investors?
- Idun Pharmaceuticals's investors include Prospect Venture Partners, Venrock, MPM BioImpact, RBC Capital, Sutter Hill Ventures.
- How much funding has Idun Pharmaceuticals raised?
- Idun Pharmaceuticals has disclosed $3.1M raised across 2 rounds.
- Where is Idun Pharmaceuticals headquartered?
- Idun Pharmaceuticals is headquartered in San Diego, US.